0.02Open0.02Pre Close0 Volume115 Open Interest65.00Strike Price0.00Turnover88.26%IV18.07%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.0086Delta0.0035Gamma3965.50Leverage Ratio-0.0158Theta-0.0001Rho-34.22Eff Leverage0.0018Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet